The Latest Breaking News from Cathie Wood

The Dow Jones powered higher. A Cathie Wood buy was surging as Biogen exploded. Coinbase stock jumped as Bitcoin rose. Apple stock dived.

When trying to identify turns in the market and depending on the current market conditions, there are certain issues that are ahead of the broad markets. At this time, ARK Innovation ETF (NYSE: ARKK) is one of them and is Monday's PreMarket Prep Stock of the Day.

 

Cryptocurrency lending platform Celsius' (CEL) move to halt withdrawals has rocked the already bearish cryptocurrency markets, but Cathie Wood's Ark Investment Management sees a silver lining in this cloud for patient investors.

Cathie Wood stocks have been foundering for the past few months owing to volatile market conditions caused in-part by aggressive Federal Reserve interest rate hikes. So, given their companies’ bleak financials and relative overvaluation, we think it could be wise to avoid popular Cathie Wood stocks Roku (ROKU), Teladoc (TDOC),…

Cathie Wood's investment strategy deserves some attention. Not because it should be modeled, but because investors can learn from the Ark Invest CEO's mistakes and hope to avoid falling into the same traps.

Institutional investor Cathie Wood’s funds have been declining sharply over the past year amid a broad selloff in stocks due to macro headwinds, including skyrocketing inflation, the Fed’s hawkish monetary stance, climbing U.S. Treasury yields, and the consequences of intense economic sanctions imposed on Russia. Owing to their poor earnings…

Due to the recent tech selloff, renowned investor Cathie Wood’s flagship Ark innovation ETF has retreated from its 2021 highs this year. However, accelerated digitalization, increasing tech dependence, and growing IT spending should allow Wood’s portfolio to rebound quickly. Given these factors, Wall Street analysts expect Wood’s beaten-down tech stock…

Renowned investor Cathie Wood of ARK Invest is known for her eye for stocks with enormous upside potential. Despite recent macro headwinds, the biotech industry is expected to grow tremendously in 2022, supported by strong demand for healthcare and medical products and increasing investments in R&D. Given these factors, Wall…

ARK Innovation ETF (NYSE: ARKK) shares ended Friday's session higher, despite being downgraded by Morningstar on risk management concerns.

Cathie Wood-led Ark Investment Management on Tuesday bought 11,143 shares in BYDCo (OTC: BYDDY), estimated to be worth $498,760 based on their last closing price, further raising its bets on the Chinese automaker that is quickly switching to making n